Status:
COMPLETED
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Lead Sponsor:
International Breast Cancer Research Foundation
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
This trial tests surgical oophorectomy (removal of ovaries) plus Tamoxifen, done at different times in the menstrual cycle, as adjuvant therapy for invasive breast cancer in 510 premenopausal women wi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Open for accrual in Asia only
- Female age 18-50,
- premenopausal with regular cycles (\>25-35 in length)
- fine-needle aspiration diagnosis
- Stage II-IIIA hormone receptor positive invasive breast cancer
- No prior radiation or chemotherapy
- Must be surgical candidate for bilateral oophorectomy
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT00201851
Start Date
January 1 2004
End Date
May 1 2013
Last Update
April 29 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Oncology
Rabat, Morocco
2
Vicente Soto Memorial Medical Center
Cebu, Philippines
3
East Avenue Medical Center
Manila, Philippines
4
Philippine General Hospital
Manila, Philippines